您好,欢迎光临世界标品! 登录 注册(订药物标准品请用邮件联系我们)

中国医药研发对照标品提供商
Non-clinical Research-used
Medicine Sample Provider

当前本网站药物产品种数共 8473 处方药 8099 非处方药 268 保健品/医疗用具 106

世界标品医药目录搜索(中英文):
世界各国官方药品目录搜索(英文):
世界标品医药知识搜索(中英文):

联系方式
国内客服电话:
国际免费电话:


QQ客服1:1793093587
QQ客服2:1586083059
QQ客服3:2786706041
QQ客服6:2992753224
QQ客服7:2394834588

咨询邮箱:
scimed.shanghai@shijiebiaopin.com
info@shijiebiaopin.com
pharmacy.shijiebiaopin1@gmail.com
pharmacy.shijiebiaopin2@gmail.com

  药店国别: 日本药房
产地国家: 日本
所属类别: 泌尿生殖系统及泌乳药物->高尿酸血症
处方药:处方药
包装规格: 1克/包 90包
计价单位:
   
生产厂家英文名:
Nippon
原产地英文商品名:
Uralyt-U (ウラリット-U) Combination Powder 1g/bag 90bags
原产地英文药品名:
Potassium citrate, Sodium citrate
中文参考商品译名:
Uralyt-U (ウラリット-U) 配合散 1克/包 90包
中文参考药品译名:
柠檬酸钾,柠檬酸钠
原产地国家批准上市年份:
0000/00/00
英文适应病症1:
gout
英文适应病症2:
acidic urine accompanied by hyperuricemia and acidosis
临床试验期:

中文适应病症参考翻译1:
痛风
中文适应病症参考翻译2:
酸性尿伴有高尿酸血症和酸中毒
药品信息:
简介: 部份中文柠檬酸钠处方资料(仅供参考) 英文药名:Uralyt(Sodium citrate tribasic hydrate) 中文药名:柠檬酸钠配合散 生产厂家:日本化学药品 适应症: 酸性尿高尿酸血症和痛风的改善 酸中毒的改进 用法与用量 ・柠檬酸钠配合散 酸性尿高尿酸血症和痛风的改善 其口服给药三次,每天一次,通常1克成年人,使其落在从6.8 pH6.2在尿检的范围内调整剂量。 酸中毒的改进 口服给药分为3-4次,日剂量6克成人原则上,但也可以根据根据患者的年龄的情况,体重,如从血液气体分析的结果来调整。 ・柠檬酸钠配合片 酸性尿高尿酸血症和痛风的改善 每天2粒一旦成年三倍,但使得它落在从6.8 pH6.2尿测试的范围内调整剂量。 酸中毒的改进 口服给药分为3-4次的12片,每日剂量成人原则上,但也可以根据根据患者的年龄的情况,体重,如从血液气体分析的结果来调整。 Japanese chemical Package insert Therapeutic category name Alkalizing therapy - acidic urine-acidosis improvement - Brand Name Uraritto -U compounding distributed Composition The following ingredients are (as dry weight) contained in the 1g. Potassium citrate ·········· 463mg (Day office) sodium citrate hydrate ····· 390mg Additive As an additive, Yellow No. 5, anhydrous citric acid, it contains lemon oil. Efficacy or effect Improvement of acidic urine in gout and hyperuricemia Uraritto -U compounding distributed Usually administered orally three times a day once 1g adult, but to adjust the dosage so as to fall within the scope of the urine test from pH6.2 6.8. Uraritto Combination Tablets Usually administered orally three times a day adult once two tablets, but to adjust the dosage so as to fall within the scope of the urine test from pH6.2 6.8. Improvement of acidosis Uraritto -U compounding distributed In principle, the oral administration of the adult daily dose 6g is divided into three or four times as but, age, body weight, will be appropriately increased or decreased depending from such as blood gas analysis results to the patient's situation. Uraritto Combination Tablets In principle the adult daily dose 12 tablets is divided into three or four times as to oral administration, but the age, body weight, will be appropriately increased or decreased depending from such as blood gas analysis results to the patient's situation. Careful administration Patients with severe renal failure [Which may increase the serum potassium level. ] Patients with liver disease, liver dysfunction [Which may worsen the symptoms. ] Patients with urinary tract infection [There is a risk of promoting infection. ] Pharmacology Mechanism of action Action of the drug is primarily bicarbonate metabolites (HCO3-) are considered to be based on to act as a base in vivo. Acidic urine improvement action 9-11) It showed a dose-dependent acidic urine preventive and therapeutic effect in ammonium chloride-induced acidic urine rat. For acidic urine uric acid-induced high uric acid blood disease rats showed elevated action of bicarbonate concentration and urinary pH in the urine. Also in uric acid-induced high uric acid blood disease rat, solubility and suppressed the deposition of the kidney tissue of uric acid to be reduced in the acidic side. Acidosis improving action 9) In the maleic acid-induced acidosis rats reduced blood pH, bicarbonate concentration, it was dose-dependently increased the base excess. The physicochemical knowledge of active ingredient Generic name Potassium citrate (Potassium Citrate) Chemical name Tripotassium 2-hydroxypropane-1,2,3-tricarboxylate hydrate Molecular formula C6H5K3O7 · H2O Molecular weight 324.41 Behavior Potassium citrate is a colorless crystal or white crystalline powder. It is very soluble in water, slightly less soluble in acetic acid (100), and practically insoluble in ethanol (95). Generic name Sodium hydrate citric acid (Sodium Citrate Hydrate) Chemical name Trisodium 2-hydroxypropane-1,2,3-tricarboxylate dihydrate Molecular formula C6H5Na3O7 · 2H2O Molecular weight 294.10 Behavior Sodium hydrate citric acid is a colorless crystal or white crystalline powder, no smell, there is a refreshing salty taste. It is freely soluble in water, and practically insoluble in ethanol (95) or diethyl ether.gout
更新日期: 2016-08-04
附件:
201681620352914.pdf    

 
调控比例: 100%
订购表单下载
Copyrights © 2010,2011,2012 www.ShiJieBiaoPin.com, Inc., All rights Reserved www.ShiJieBiaoPin.com, Inc.
客服工作时间:太平洋时间18:00-24:00
国内客服电话:     国际免费电话:
友情提示:以上电话为免费电话,无需您承担任何费用,世界标品提供中文客服,请您放心拨打!
电子邮箱:info.shijiebiaopin.com@gmail.com, info@shijiebiaopin.com